RENAL CELL CARCINOMA METASTATIC
Clinical trials for RENAL CELL CARCINOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new RENAL CELL CARCINOMA METASTATIC trials appear
Sign up with your email to follow new studies for RENAL CELL CARCINOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Kidney cancer trial: to cut or not to cut after immunotherapy?
Disease control Recruiting nowThis study looks at whether removing the kidney tumor after starting immunotherapy helps people with advanced kidney cancer live longer. About 400 participants will be randomly assigned to have surgery or not. The goal is to see if delayed surgery improves overall survival compar…
Matched conditions: RENAL CELL CARCINOMA METASTATIC
Phase: NA • Sponsor: Niels Fristrup • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New antibody targets FGFR1 to fight metastatic cancers
Disease control Recruiting nowThis study tests a new drug called OM-RCA-01, an antibody that blocks a protein called FGFR1 found on some cancer cells. About 58 adults with metastatic kidney, lung, prostate, breast, or head and neck cancers that express FGFR1 will receive the drug by IV every two weeks. The go…
Matched conditions: RENAL CELL CARCINOMA METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Kidney Cancer Research Bureau • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New trial aims to boost survival in kidney cancer by combining radiation with drug therapy
Disease control Recruiting nowThis Phase III trial is testing whether adding a precise type of radiation (SBRT) to standard drug therapy (targeted drugs and/or immunotherapy) can help people with kidney cancer that has spread to up to five spots live longer without the disease getting worse. The study will en…
Matched conditions: RENAL CELL CARCINOMA METASTATIC
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Blood tests could make kidney cancer drugs safer and more effective
Knowledge-focused Recruiting nowThis study tracks drug levels in the blood of 200 people with advanced kidney cancer to see if monitoring can improve how well the drugs work and reduce side effects. Researchers will also look at how the body's immune system and genes affect treatment. The goal is to find better…
Matched conditions: RENAL CELL CARCINOMA METASTATIC
Sponsor: Niels Fristrup • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC